Sanofi is set to release its quarterly earnings on October 24, 2025, with an expected EPS of $1.60 and revenue of approximately$12.4 billion.The company's recent success with efdoralprin alfa in the ElevAATe phase II study highlights its commitment to innovation and potential market growth.Financial metrics such as a P/E ratio of 11.66, enterprise value to operating cash flow ratio of 54.30, and a current ratio of 1.27 indicate Sanofi's stable financial position and market valuation.Sanofi (NASDAQ:SNY) is ...